Details for New Drug Application (NDA): 062757
NDA 062757 describes MEFOXIN, which is a drug marketed by Pharmobedient and Merck and is included in four NDAs. Additional details are available on the MEFOXIN profile page.
The generic ingredient in MEFOXIN is cefoxitin sodium. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
The generic ingredient in MEFOXIN is cefoxitin sodium. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for 062757
| Tradename: | MEFOXIN |
| Applicant: | Pharmobedient |
| Ingredient: | cefoxitin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062757
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Jan 8, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Jan 8, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
